A role borne by a molecule that acts to counteract or neutralize the deleterious effects of curare.
ChEBI ID: 74530
Member | Definition | Class |
---|---|---|
galantamine | A benzazepine alkaloid isolated from certain species of daffodils. | galanthamine |
neostigmine | A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor. | neostigmine |
pantothenic acid | A pantothenic acid having R-configuration. | (R)-pantothenic acid |
physostigmine | physostigmine |
Timeframe | Studies, Drugs with This Role(%) | All Drugs % |
---|---|---|
pre-1990 | 8,638 (60.57) | 18.7374 |
1990's | 1,667 (11.69) | 18.2507 |
2000's | 1,728 (12.12) | 29.6817 |
2010's | 1,686 (11.82) | 24.3611 |
2020's | 542 (3.80) | 2.80 |
Publication Type | Studies, Drugs with this Role (%) | All Drugs (%) |
---|---|---|
Trials | 1,027 (6.36%) | 5.53% |
Reviews | 781 (4.84%) | 6.00% |
Case Studies | 743 (4.60%) | 4.05% |
Observational | 43 (0.27%) | 0.25% |
Other | 13,557 (83.94%) | 84.16% |
Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
---|---|---|---|---|---|
acetylcholinesterase | Homo sapiens (human) | Potency | 0.5381 | 4 | 8 |
aldehyde dehydrogenase 1 family, member A1 | Homo sapiens (human) | Potency | 14.9872 | 1 | 2 |
AR protein | Homo sapiens (human) | Potency | 6.8590 | 1 | 1 |
aryl hydrocarbon receptor | Homo sapiens (human) | Potency | 61.5362 | 2 | 2 |
arylsulfatase A | Homo sapiens (human) | Potency | 19.1172 | 1 | 2 |
atrial natriuretic peptide receptor 1 precursor | Homo sapiens (human) | Potency | 23.9341 | 1 | 1 |
Bloom syndrome protein isoform 1 | Homo sapiens (human) | Potency | 0.2818 | 2 | 2 |
Chain A, 2-oxoglutarate Oxygenase | Homo sapiens (human) | Potency | 39.8107 | 1 | 1 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | 15.8114 | 1 | 1 |
cytochrome P450 2D6 | Homo sapiens (human) | Potency | 0.9772 | 1 | 1 |
estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 0.0049 | 1 | 1 |
euchromatic histone-lysine N-methyltransferase 2 | Homo sapiens (human) | Potency | 19.6799 | 1 | 3 |
EWS/FLI fusion protein | Homo sapiens (human) | Potency | 28.7026 | 4 | 4 |
geminin | Homo sapiens (human) | Potency | 1.4581 | 1 | 1 |
GLI family zinc finger 3 | Homo sapiens (human) | Potency | 61.1306 | 1 | 1 |
GLS protein | Homo sapiens (human) | Potency | 18.5412 | 2 | 4 |
glucocorticoid receptor [Homo sapiens] | Homo sapiens (human) | Potency | 27.5900 | 1 | 2 |
glucokinase regulatory protein | Homo sapiens (human) | Potency | 10.0000 | 1 | 1 |
hexokinase-4 isoform 1 | Homo sapiens (human) | Potency | 10.0000 | 1 | 1 |
histone acetyltransferase KAT2A isoform 1 | Homo sapiens (human) | Potency | 39.8107 | 1 | 1 |
IDH1 | Homo sapiens (human) | Potency | 12.9953 | 1 | 1 |
lamin isoform A-delta10 | Homo sapiens (human) | Potency | 13.4991 | 1 | 3 |
M-phase phosphoprotein 8 | Homo sapiens (human) | Potency | 31.6228 | 1 | 1 |
muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | Potency | 6.7834 | 2 | 2 |
nonstructural protein 1 | Influenza A virus (A/WSN/1933(H1N1)) | Potency | 25.1189 | 1 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 44.5346 | 3 | 3 |
peripheral myelin protein 22 | Rattus norvegicus (Norway rat) | Potency | 21.6028 | 2 | 2 |
pregnane X nuclear receptor | Homo sapiens (human) | Potency | 34.3762 | 1 | 1 |
RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 15.9556 | 2 | 2 |
regulator of G-protein signaling 4 | Homo sapiens (human) | Potency | 0.0752 | 1 | 1 |
Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | Potency | 25.1189 | 1 | 1 |
survival motor neuron protein isoform d | Homo sapiens (human) | Potency | 28.1838 | 1 | 1 |
TDP1 protein | Homo sapiens (human) | Potency | 9.4411 | 1 | 1 |
thioredoxin reductase | Rattus norvegicus (Norway rat) | Potency | 29.9349 | 1 | 1 |
vitamin D3 receptor isoform VDRA | Homo sapiens (human) | Potency | 89.1251 | 1 | 1 |
Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
---|---|---|---|---|---|
Acetylcholinesterase | Electrophorus electricus (electric eel) | IC50 | 5.8703 | 107 | 128 |
Acetylcholinesterase | Gallus gallus (chicken) | IC50 | 0.0200 | 1 | 1 |
Acetylcholinesterase | Homo sapiens (human) | IC50 | 17.1474 | 109 | 126 |
Acetylcholinesterase | Mus musculus (house mouse) | IC50 | 0.9321 | 5 | 5 |
Acetylcholinesterase | Rattus norvegicus (Norway rat) | IC50 | 0.3578 | 9 | 12 |
Acetylcholinesterase | Tetronarce californica (Pacific electric ray) | IC50 | 0.4374 | 10 | 11 |
Acetylcholinesterase | Electrophorus electricus (electric eel) | Ki | 1.0870 | 6 | 6 |
Acetylcholinesterase | Homo sapiens (human) | Ki | 11.9456 | 5 | 6 |
Acetylcholinesterase | Tetronarce californica (Pacific electric ray) | Ki | 16.0950 | 1 | 2 |
Acetylcholinesterase | Bos taurus (cattle) | IC50 | 1.9898 | 5 | 6 |
Acyl-CoA:cholesterol acyltransferase | Oryctolagus cuniculus (rabbit) | IC50 | 0.0189 | 1 | 1 |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 0.8570 | 1 | 1 |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 0.8570 | 1 | 1 |
Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 0.8570 | 1 | 1 |
ATP-binding cassette sub-family C member 3 | Homo sapiens (human) | IC50 | 133.0000 | 1 | 2 |
Bile salt export pump | Homo sapiens (human) | IC50 | 505.1429 | 4 | 7 |
Bile salt export pump | Rattus norvegicus (Norway rat) | IC50 | 1,000.0000 | 1 | 1 |
Canalicular multispecific organic anion transporter 1 | Homo sapiens (human) | IC50 | 133.0000 | 1 | 2 |
Carboxylic ester hydrolase | Equus caballus (horse) | IC50 | 8.9098 | 10 | 12 |
Carboxylic ester hydrolase | Rattus norvegicus (Norway rat) | IC50 | 0.0180 | 3 | 3 |
Carboxylic ester hydrolase | Equus caballus (horse) | Ki | 8.0000 | 1 | 1 |
Chain A, ACETYLCHOLINESTERASE | Tetronarce californica (Pacific electric ray) | IC50 | 0.5060 | 1 | 2 |
Cholinesterase | Equus caballus (horse) | IC50 | 13.8596 | 60 | 65 |
Cholinesterase | Homo sapiens (human) | IC50 | 566,903,896,477.0687 | 63 | 77 |
Cholinesterase | Mus musculus (house mouse) | IC50 | 0.2800 | 2 | 2 |
Cholinesterase | Equus caballus (horse) | Ki | 3.8705 | 2 | 2 |
Cholinesterase | Homo sapiens (human) | Ki | 17.4458 | 5 | 6 |
Cytochrome P450 2D6 | Homo sapiens (human) | IC50 | 0.2000 | 1 | 1 |
Cytochrome P450 3A4 | Homo sapiens (human) | IC50 | 12.7300 | 1 | 1 |
Delta-type opioid receptor | Mus musculus (house mouse) | IC50 | 4.7897 | 1 | 4 |
Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | IC50 | 3.2000 | 1 | 1 |
Multidrug resistance-associated protein 4 | Homo sapiens (human) | IC50 | 133.0000 | 1 | 2 |
Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | IC50 | 160.0000 | 1 | 1 |
Prolyl endopeptidase | Homo sapiens (human) | IC50 | 200.0000 | 1 | 1 |
Small conductance calcium-activated potassium channel protein 3 | Rattus norvegicus (Norway rat) | IC50 | 12.7000 | 1 | 1 |
Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | IC50 | 0.5900 | 1 | 1 |
Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | IC50 | 0.5900 | 1 | 1 |
Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | IC50 | 0.5900 | 1 | 1 |
Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
---|---|---|---|---|---|
Acetylcholinesterase | Homo sapiens (human) | EC50 | 1.1000 | 1 | 1 |
Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
---|---|---|---|---|---|
Acetylcholinesterase | Electrophorus electricus (electric eel) | K | 0.0343 | 1 | 1 |
Acetylcholinesterase | Homo sapiens (human) | Kc | 0.2500 | 1 | 1 |
Acetylcholinesterase | Homo sapiens (human) | MIC | 0.0000 | 1 | 1 |
Cholinesterase | Equus caballus (horse) | K | 0.1208 | 3 | 3 |
Type II pantothenate kinase | Staphylococcus aureus subsp. aureus MSSA476 | Km | 19.0000 | 1 | 1 |
Type III pantothenate kinase | Pseudomonas aeruginosa PAO1 | Km | 20.0000 | 1 | 1 |